CSIMarket
 


Atara Biotherapeutics Inc   (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's Income from Cont. Operations Growth by Quarter and Year

Atara Biotherapeutics Inc 's Income from Cont. Operations results by quarter and year




ATRA Income from Cont. Operations (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -92.03 -80.01 -35.31
III Quarter September - -71.90 -58.36 -31.10
II Quarter June -77.46 -74.33 -50.88 -27.43
I Quarter March -73.51 -66.26 -41.44 -25.65
FY   -150.97 -304.52 -230.69 -119.49



ATRA Income from Cont. Operations second quarter 2020 Y/Y Growth Comment
Atara Biotherapeutics Inc in the second quarter recorded loss from continued operations of $ -77.46 millions.

According to the results reported in the second quarter, Atara Biotherapeutics Inc achieved the best Income from Cont. Operations growth in Biotechnology & Drugs industry. While Atara Biotherapeutics Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. in the second quarter.




ATRA Income from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics Inc 's second quarter 2020 Income from Cont. Operations $ -77.46 millions ATRA's Income Statement
Atara Biotherapeutics Inc 's second quarter 2019 Income from Cont. Operations $ -74.33 millions Quarterly ATRA's Income Statement
New: More ATRA's historic Income from Cont. Operations Growth >>


ATRA Income from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Atara Biotherapeutics Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's II. Quarter Q/Q Income from Cont. Operations Comment
Recent loss from continued operations of -77.46 millions by Atara Biotherapeutics Inc appear even worse compare to the -73.51 millions in the first quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics Inc achieved highest sequential Income from Cont. Operations growth. While Atara Biotherapeutics Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's II. Quarter Q/Q Income from Cont. Operations Comment
II. Quarter 2020 accomplishment of -77.46 millions by Atara Biotherapeutics Inc appear even worse compare to the -73.51 millions in the previous quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics Inc achieved highest sequential Income from Cont. Operations growth. While Atara Biotherapeutics Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Atara Biotherapeutics Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
Cumulative Income from Cont. Operations 12 Months Ending $ -314.89 $ -311.76 $ -312.63 $ -292.49 $ -278.96
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Atara Biotherapeutics Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -315 millions in the Jun 30 2020 period.
The situation is detiriorating as the cumulative loss from continued operations is getting bigger from $ -311.76 millions for the period from Mar 31 2020 to Jun 30 2019 and $ -73.51 millions for the twelve months ending in the quarter Jun 30 2019 Sierra C. Taylor told.

Atara Biotherapeutics Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Atara Biotherapeutics Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -315 millions in the Jun 30 2020 period.
The situation is detiriorating as the cumulative loss from continued operations is getting bigger from $ -311.76 millions in TTM ending quarter Mar 31 2020 and $ -73.51 millions for the twelve months ending in the quarter Jun 30 2019.

Atara Biotherapeutics Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Biotechnology & Drugs Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
ATRA's Income from Cont. Operations Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for ATRA's Competitors
Income from Cont. Operations Growth for Atara Biotherapeutics Inc 's Suppliers
Income from Cont. Operations Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Jun 30 2020 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Jun 30 2020
Eli Lilly And Company  6.39 %$ 6.389 millions
Universal Health Services Inc  6.32 %$ 6.316 millions
National Research Corporation  4.36 %$ 4.355 millions
Steris Plc  3.95 %$ 3.948 millions
Amedisys Inc  3.25 %$ 3.252 millions
Davita Inc   2.84 %$ 2.842 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TLND's Profile

Stock Price

TLND's Financials

Business Description

Fundamentals

Charts & Quotes

TLND's News

Suppliers

TLND's Competitors

Customers & Markets

Economic Indicators

TLND's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071